We are proud to offer a wide range of molecular diagnostic solutions (Molecular Diagnostic Supplier) Real Time PCR Testing that cater to the needs of healthcare professionals and laboratories. Our product offerings include major test panels and molecular kits that utilize Molecular Diagnostics, RT-PCR, Iso Thermal and other POCT methods. Explore the following sections to learn more about the panels we offer:
Our solution covers range of sexually transmitted infections, including;
A panel that detects high-risk HPV genotypes associated with cervical cancer and other HPV-related diseases. It helps in early detection, monitoring, and risk assessment.
Hepatitis B Virus (HBV) Qualitative and Quantitative Panels: Panel detects and quantifies HBV DNA, allowing for the diagnosis and monitoring of HBV infection.
Hepatitis C Virus (HCV) Qualitative and Quantitative Panels: Panel designed to detect and quantify HCV RNA, aiding in the diagnosis, staging, and monitoring of HCV infection.
Human Immunodeficiency Virus (HIV) Panel: This panel enables the detection and quantification of HIV-1 RNA, facilitating the diagnosis, monitoring, and management of HIV infection.
Respiratory Infection Panel: This panel targets a wide range of respiratory pathogens, including bacteria and viruses, assisting in the diagnosis and management of respiratory infections.
COVID-19 Panel: A comprehensive panel designed to detect and diagnose COVID-19 infections. It includes specific primers and probes for the detection of SARS-CoV-2.
Respiratory Pathogen Panel: This panel detects a broad range of respiratory pathogens, including:
A panel designed to identify common gastrointestinal pathogens, such as bacteria, viruses, and parasites, responsible for gastroenteritis. Entamoeba histolytica, Cryptosporidium spp, Giardia lamblia, Cyclospora cayetanensis, Vibrio vulnificus, Vibrio parahaemolyticus, Vibrio cholera, Campylobacter spp. (C. jejuni, C. upsaliensis, C. coli, Salmonella spp, Clostridium difficile (tcdA/tcdB, Yersinia enterocolitica, Enteroaggregative E. coli (EAEC, Enterotoxigenic E. coli (ETEC), Shiga-like toxin-producing E. coli (STEC), Shiga toxin-producing E. coli (STEC) serotype O157:H7, Enteropathogenic E. coli (EPEC), Enteroinvasive E. coli (EIEC)/Shigella, Plesiomonas shigelloides, Human Adenovirus F40/F41, Norovirus GI, Norovirus GII, Rotavirus A, Astrovirus, Sapovirus GI, GII, GIV, GV.
Solid Tumor Panel: This panel is designed to detect specific genetic mutations associated with solid tumors, aiding in diagnosis, prognosis, and personalized treatment options.
Hematological Malignancy Panel: A comprehensive panel that targets genetic alterations in hematological malignancies, helping clinicians in disease classification and treatment decisions.
Chronic myelogenous leukaemia (CML): results from the neoplastic transformation of a haematopoietic stem cell. The hallmark genetic abnormality of CML is a t(9;22)(q34;q11) translocation, which was first discovered as an abnormal, small chromosome, named the ‘Philadelphia chromosome’. This translocation generates the BCR – ABL fusion gene.
Carrier Screening Panel: This panel assists in identifying carrier status for a wide range of genetic disorders, providing valuable information for family planning and reproductive decision-making.
Pharmacogenetics Panel: A panel that analyzes genetic variations relevant to drug metabolism and response, enabling personalized medicine approaches and optimizing treatment outcomes.
HLA Typing Panel: This panel determines human leukocyte antigen (HLA) compatibility between donors and recipients for solid organ and stem cell transplantation.
Viral Load Monitoring Panel: A panel that quantifies viral load in transplant patients, allowing early detection of viral reactivation and appropriate intervention.
Bacterial Meningitis Panel: This panel identifies common bacterial pathogens responsible for meningitis, aiding in prompt diagnosis and appropriate treatment.
Tuberculosis (TB) Panel: A panel that detects Mycobacterium tuberculosis, the causative agent of tuberculosis, enabling early diagnosis and monitoring of treatment response.
Unlock the true potential of molecular diagnostics with our state-of-the-art automated solutions for DNA and RNA purification. Built on cutting-edge technology, our innovative platforms streamline and optimize the nucleic acid extraction process, providing researchers, clinicians, and diagnostic laboratories with unparalleled efficiency and accuracy. By harnessing the power of robotics, AI algorithms, and standardized protocols, our automated systems deliver rapid and reliable sample processing, ensuring consistent and high-quality results. Experience the future of nucleic acid extraction and empower your scientific endeavors with our advanced automated solutions for DNA and RNA purification.